| [1] |
Kubo S. Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy[J]. Clin J Gastroenterol, 2009, 2(2): 65-70.
|
| [2] |
Zhao Y, Li Y, Ma H, et al. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma[J]. Mol Cell Proteomics, 2014,13(2): 520-536.
|
| [3] |
Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses[J]. Nat Rev Immunol, 2009, 9(8): 581-593.
|
| [4] |
Forner A, Bruix J. Biomarkers for early diagnosis of hepatocellular carcinoma[J]. Lancet Oncol, 2012, 13(8): 750-751.
|
| [5] |
Dyson J, Jaques B, Chattopadyhay D, et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team[J].J Hepatol, 2014, 60(1): 110-117.
|
| [6] |
Johnstone RM, Adam M, Hammond JR, et al. Vesicle formation during reticulocyte maturation. association of plasma membrane activities with released vesicles (exosomes)[J]. J Biol Chem, 1987, 262(19): 9412-9420.
|
| [7] |
Théry C. Exosomes: secreted vesicles and intercellular communications[J]. F1000 Biol Rep, 2011(3): 15.
|
| [8] |
Zhang C, Yang X, Qi Q, et al. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma[J]. Cancer Biomark, 2018, 21(3): 651-659.
|
| [9] |
Zhao X, Wu Y, Duan J, et al. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS[J]. J Proteome Res, 2014, 13(12): 5391-5402.
|
| [10] |
Zhang J, Lu S, Zhou Y, et al. Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes[J]. Proteomics, 2017, 17(13/14): 1700103.
|
| [11] |
He M, Qin H, Poon TC, et al. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs[J]. Carcinogenesis, 2015, 36(9): 1008-1018.
|
| [12] |
Zhu L, Qu XH, Sun YL, et al. Novel method for extracting exosomes of hepatocellular carcinoma cells[J]. World J Gastroenterol, 2014, 20(21): 6651-6657.
|
| [13] |
Wang H, Hou L, Li A, et al. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma[J]. Biomed Res Int, 2014: 864894.
|
| [14] |
Sugimachi K, Matsumura T, Hirata H, et al. Identification ofa bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation[J]. Br J Cancer, 2015, 112(3): 532-538.
|
| [15] |
Sohn W, Kim J, Kang SH, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma[J]. Exp Mol Med, 2015(47): e184.
|
| [16] |
Fornari F, Ferracin M, Trerè D, et al. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, identify cirrhotic patients with HCC[J]. PLoS One, 2015, 10(10): e0141448.
|
| [17] |
Chiba M, Kimura M, Asari S. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines[J]. Oncol Rep, 2012, 28(5): 1551-1558.
|
| [18] |
Xue X, Wang X, Zhao Y, et al. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A[J]. Biochem Biophys Res Commun, 2018, 502(4): 515-521.
|
| [19] |
Zhang Z, Li X, Sun W, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis[J]. Cancer Lett, 2017, 397: 33-42.
|
| [20] |
Fujiki T, Miura T, Maura M, et al. TAK1 represses transcription of the human telomerase reverse transcriptase gene[J]. Oncogene, 2007, 26(36): 5258-5266.
|
| [21] |
Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth[J]. Hepatology, 2011, 54(4): 1237-1248.
|
| [22] |
Fang T, Lv H, Lv G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1): 191.
|
| [23] |
Conigliaro A, Costa V, Lo Dico A, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J]. Mol Cancer, 2015(14): 155.
|
| [24] |
Ikeda Y, Imai Y, Kumagai H, et al. Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo[J]. Proc Natl Acad Sci U S A, 2004, 101(29): 10732-10737.
|
| [25] |
Ramakrishnaiah V, Thumann C, Fofana I, et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells[J]. Proc Natl Acad Sci U S A, 2013, 110(32): 13109-13113.
|
| [26] |
Yang Y, Han Q, Hou Z, et al. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction[J]. Cell Mol Immunol, 2017, 14(5): 465-475.
|
| [27] |
Xiao W, Dong W, Zhang C, et al. Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells[J]. Eur J Med Res, 2013(18): 61.
|
| [28] |
Xiao WH, Sanren GW, Zhu JH, et al. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma[J]. World J Gastroenterol, 2010, 16(19): 2371-2377.
|
| [29] |
Lv LH, Wan YL, Lin Y, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro[J]. J Biol Chem, 2012, 287(19): 15874-15885.
|
| [30] |
Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J]. Nat Cell Biol, 2007, 9(6): 654-659.
|
| [31] |
Wang F, Li L, Piontek K, et al. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3): 940-954.
|
| [32] |
Pan Q, Ramakrishnaiah V, Henry S, et al. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi)[J]. Gut, 2012, 61(9): 1330-1339.
|
| [33] |
Wei JX, Lv LH, Wan YL, et al. Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells[J]. Hepatology, 2015, 61(4): 1284-1294.
|
| [34] |
Qi H, Liu C, Long L, et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy[J]. ACS Nano, 2016, 10(3): 3323-3333.
|
| [35] |
Qu Z, Wu J, Wu J, et al. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro[J]. J Exp Clin Cancer Res, 2016, 35(1): 159.
|
| [36] |
Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma[J]. J Hematol Oncol, 2015(8): 122.
|
| [37] |
Takahashi K, Yan IK, Wood J, et al. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy[J]. Mol Cancer Res, 2014, 12(10): 1377-1387.
|
| [38] |
马博，任军，姜晗昉，等．肿瘤源性外切体负载的间充质干细胞抗肿瘤活性的实验研究[J]．北京大学学报（医学版），2008, 40(5): 494-499.
|
| [39] |
Lu Z, Zuo B, Jing R, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models[J]. J Hepatol, 2017, 67(4): 739-748.
|